Notícias Spyre Therapeutics Inc - SYRE | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Spyre Therapeutics Inc (SYRE)
Spyre Therapeutics Inc (SYRE) Notícias

Spyre Therapeutics Inc (SYRE)

18,115

-0,765

( -4,05% )

Atualizado: 12:57:11

Atrasado por 15 minutos

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

Form EFFECT - Notice of Effectiveness

Form POS AM - Post-Effective amendments for registration statement

Spyre Therapeutics Announces Grants of Inducement Awards

Form S-3 - Registration statement under Securities Act of 1933

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Spyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Spyre Therapeutics to Participate in Upcoming March Investor Conferences

Spyre Therapeutics Announces Poster Presentation at the 20th Congress of the European Crohn's and Colitis Organisation

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Spyre Therapeutics Announces Grants of Inducement Awards

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Spyre Therapeutics

BNP Paribas Issuance

BNP PARIBAS ISSUANCE

Xtrackers Treasuries Ult...

Lyxor Esg Usd High Yield...

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições